An update on nanoformulations with FDA approved drugs for female reproductive cancer DOI

M. Thanga Raj,

Abha Meena, Richa Seth

и другие.

Journal of Microencapsulation, Год журнала: 2025, Номер unknown, С. 1 - 34

Опубликована: Март 20, 2025

Female reproductive cancers, including ovarian, cervical, breast, gestational trophoblastic and endometrial cancer, present significant challenges in therapy patient prognosis. Conventional chemotherapy often lacks selectivity, leading to systemic toxicity reduced treatment efficacy. Nanotechnology has emerged as a promising approach improve drug delivery therapeutic outcomes. Encapsulation of FDA-approved drugs within nanocarriers such liposomes, polymeric nanoparticles, lipid nanoparticles enables controlled release, reduces off-target effects, enhances accumulation at tumor sites. This targeted minimizes damage healthy tissues improves survival rates. Additionally, nanoformulations facilitate combination therapy, overcoming resistance maximizing Despite results, like scalability, reproducibility, regulatory approvals hinder widespread clinical applications. Developing personalized tailored individual profiles offers potential for precision cancer therapy. study explores the role enhancing treating female cancers.

Язык: Английский

Repurposing AS1411 for constructing ANM-PROTACs DOI
Xuekun Fu, Jin Li, Xinxin Chen

и другие.

Cell chemical biology, Год журнала: 2024, Номер 31(7), С. 1290 - 1304.e7

Опубликована: Апрель 23, 2024

Язык: Английский

Процитировано

10

Programmed cell death in tumor immunity: mechanistic insights and clinical implications DOI Creative Commons

Man Wang,

Fei Yu, Yuan Zhang

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 14

Опубликована: Янв. 12, 2024

Programmed cell death (PCD) is an evolutionarily conserved mechanism of suicide that controlled by various signaling pathways. PCD plays important role in a multitude biological processes, such as turnover, development, tissue homeostasis and immunity. Some forms PCD, including apoptosis, autophagy-dependent death, pyroptosis, ferroptosis necroptosis, contribute to carcinogenesis cancer thus have attracted increasing attention the field oncology. Recently, research-based evidence has demonstrated acts critical modulator tumor can affect function innate adaptive immune cells, which leads distinct immunological consequences, priming tumor-specific T immunosuppression evasion. Targeting alone or combination with conventional immunotherapy may provide new options enhance clinical efficacy anticancer therapeutics. In this review, we introduce characteristics mechanisms ubiquitous pathways (e.g., pyroptosis ferroptosis) explore complex interaction between these immunity based on currently available evidence. We also discuss therapeutic potential PCD-based approaches outlining trials targeting treatment. Elucidating immune-related effects pathogenesis will likely improved understanding oncoimmunology allow be exploited for

Язык: Английский

Процитировано

9

Synthesis of Carbon Dots from Spent Coffee Grounds: Transforming Waste into Potential Biomedical Tools DOI Creative Commons
Yingru Zhou, Adalberto Camisasca, Sofia Dominguez‐Gil

и другие.

Nanoscale, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Carbon dots were synthesised from spent coffee grounds via a novel acetone precipitation approach, featuring superior physico-chemical properties for potential biomedical applications. Created in BioRender. Zhou, Y. (2025) https://BioRender.com/m82x982.

Язык: Английский

Процитировано

1

Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer DOI Creative Commons
Shrey Kanvinde, Tanmay A. Kulkarni, Suyash Deodhar

и другие.

BioTech, Год журнала: 2022, Номер 11(1), С. 6 - 6

Опубликована: Март 7, 2022

The research and development of non-viral gene therapy has been extensive over the past decade received a big push thanks to recent successful approval nucleic acid products. Despite these developments, applications in cancer have limited. One main causes this imbalance delivery vectors as compared with sophisticated payloads, such siRNA, mRNA, etc. This paper reviews that can be used deliver acids for treatment. It discusses various types highlights their current applications. Additionally, it perspective on regulatory landscape facilitate commercial translation therapy.

Язык: Английский

Процитировано

29

Advances and Prospects of Prolamine Corn Protein Zein as Promising Multifunctional Drug Delivery System for Cancer Treatment DOI Creative Commons
Xi Luo,

Sudan Wu,

Meng Xiao

и другие.

International Journal of Nanomedicine, Год журнала: 2023, Номер Volume 18, С. 2589 - 2621

Опубликована: Май 1, 2023

Abstract: Zein is a type of prolamine protein that derived from corn, and it has been recognized by the US FDA as one safest biological materials available. possesses valuable characteristics have made popular choice for preparation drug carriers, which can be administered through various routes to improve therapeutic effect antitumor drugs. Additionally, zein contains free hydroxyl amino groups offer numerous modification sites, enabling hybridized with other create functionalized delivery systems. However, despite its potential, clinical translation drug-loaded zein-based carriers remains challenging due insufficient basic research relatively strong hydrophobicity. In this paper, we aim systematically introduce main interactions between loaded drugs zein, administration routes, functionalization systems, in order demonstrate development potential promote their further application. We also provide perspectives future directions promising area research. Graphical Keywords: nanomedicine, delivery,

Язык: Английский

Процитировано

21

A new era in cancer treatment: harnessing ZIF-8 nanoparticles for PD-1 inhibitor delivery DOI
Farangis Rastin, Mahsa Akbari Oryani,

Sonia Iranpour

и другие.

Journal of Materials Chemistry B, Год журнала: 2023, Номер 12(4), С. 872 - 894

Опубликована: Дек. 11, 2023

This review delves into the potential of zeolitic imidazolate framework-8 (ZIF-8) nanoparticles in augmenting efficacy cancer immunotherapy, with a special focus on delivery programmed cell death receptor 1 (PD-1) inhibitors. The multifunctional nature ZIF-8 as drug carriers is emphasized, their ability to encapsulate range therapeutic agents, including PD-1 inhibitors, and facilitate targeted tumor locations. By manipulating pore size surface characteristics nanoparticles, controlled release can be realized. strategic use deliver inhibitors presents precise modality for treatment, reducing off-target impacts enhancing effectiveness. combined strategy addresses existing challenges constraints current immunotherapy techniques, ultimate goal patient outcomes therapy.

Язык: Английский

Процитировано

18

Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications DOI Creative Commons
Priyanka Singh, Santosh Pandit, Sri Renukadevi Balusamy

и другие.

Advanced Healthcare Materials, Год журнала: 2024, Номер 14(4)

Опубликована: Ноя. 6, 2024

Cancer remains one of the most challenging health issues globally, demanding innovative therapeutic approaches for effective treatment. Nanoparticles, particularly those composed gold, silver, and iron oxide, have emerged as promising candidates changing cancer therapy. This comprehensive review demonstrates landscape nanoparticle-based oncological interventions, focusing on remarkable advancements potentials oxide nanoparticles. Gold nanoparticles garnered significant attention their exceptional biocompatibility, tunable surface chemistry, distinctive optical properties, rendering them ideal various diagnostic strategies. Silver nanoparticles, renowned antimicrobial exhibit potential in therapy through multiple mechanisms, including apoptosis induction, angiogenesis inhibition, drug delivery enhancement. With magnetic properties offer unique diagnosis targeted opportunities. critically examines recent synthesis, functionalization, biomedical applications these Moreover, challenges are discussed, toxicity concerns, immunogenicity, translational barriers, ongoing efforts to overcome hurdles highlighted. Finally, insights into future directions regulatory considerations, provided aiming accelerate translation technologies from bench bedside.

Язык: Английский

Процитировано

7

AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging DOI
Mahima Chauhan,

Sonali,

Saurabh Shekhar

и другие.

Biomaterials Advances, Год журнала: 2024, Номер 160, С. 213833 - 213833

Опубликована: Март 21, 2024

Язык: Английский

Процитировано

6

Pharmaceutical Applications of Biomass Polymers: Review of Current Research and Perspectives DOI Open Access

Cornelia Bejenaru,

Antonia Radu, Adina‐Elena Segneanu

и другие.

Polymers, Год журнала: 2024, Номер 16(9), С. 1182 - 1182

Опубликована: Апрель 23, 2024

Polymers derived from natural biomass have emerged as a valuable resource in the field of biomedicine due to their versatility. Polysaccharides, peptides, proteins, and lignin demonstrated promising results various applications, including drug delivery design. However, several challenges need be addressed realize full potential these polymers. The current paper provides comprehensive overview latest research perspectives this area, with particular focus on developing effective methods efficient systems. This review aims offer insights into opportunities associated use polymers provide roadmap for future field.

Язык: Английский

Процитировано

6

A biodegradable pH and glutathione dual-triggered drug delivery system based on mesoporous silica, carboxymethyl chitosan and oxidized pullulan DOI

Rui Qian,

Jun Gao,

Zheng‐Zhi Yin

и другие.

International Journal of Biological Macromolecules, Год журнала: 2022, Номер 224, С. 1294 - 1302

Опубликована: Окт. 25, 2022

Язык: Английский

Процитировано

26